Mohamed Ayoub, Abdul Mozid, Legate Philip, Xavier Millan, Jaikirshan Khatri, Claudiu Ungureanu, Johan Bennett, Chadi Ghafari, Alexandre Avran
{"title":"Use of ReCross to Increase Success Rate With Antegrade CTO PCI-A Multicenter Observational Study.","authors":"Mohamed Ayoub, Abdul Mozid, Legate Philip, Xavier Millan, Jaikirshan Khatri, Claudiu Ungureanu, Johan Bennett, Chadi Ghafari, Alexandre Avran","doi":"10.1002/ccd.31585","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antegrade approach remains one of the predominant techniques for CTO PCI. Success rates have increased significantly recently due to advancements in devices and strategies, along with the hybrid algorithm. ReCross is a uniquely modified microcatheter with two over-the-wire lumens and three exit ports, offering significant potential for application across all facets of antegrade CTO-PCI applications. However, there is limited published data investigating its efficacy.</p><p><strong>Objective: </strong>The objective of our study was to analyze the efficiency and outcome of the ReCross device, following an agreed step-by-step protocol in contemporary CTO PCI, based on our firsthand experience.</p><p><strong>Methods: </strong>During the period between June 2023 and April 2024, we evaluated patients undergoing CTO PCI at eight participating centers for scheduled clinically necessary CTO PCI with a planned primary antegrade approach using an upfront agreed ReCross strategy.</p><p><strong>Results: </strong>A total of 118 patients who underwent CTO PCI were included in the study. The mean JCTO score was 2.16 ± 0.95. The majority of cases (94%) were successfully resolved using an upfront ReCross strategy with a technical success of 96%, demonstrating a high level of effectiveness. The average procedure time (90 min) observed in our study was notably lower in comparison to other similar studies. There were no procedure-related mortalities until hospital discharge, although one distal wire perforation complication was reported.</p><p><strong>Conclusion: </strong>Our initial experience with the ReCross microcatheter suggests in select cases with the application of a dedicated algorithm, the antegrade approach can be highly successful.</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Catheterization and Cardiovascular Interventions","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ccd.31585","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Antegrade approach remains one of the predominant techniques for CTO PCI. Success rates have increased significantly recently due to advancements in devices and strategies, along with the hybrid algorithm. ReCross is a uniquely modified microcatheter with two over-the-wire lumens and three exit ports, offering significant potential for application across all facets of antegrade CTO-PCI applications. However, there is limited published data investigating its efficacy.
Objective: The objective of our study was to analyze the efficiency and outcome of the ReCross device, following an agreed step-by-step protocol in contemporary CTO PCI, based on our firsthand experience.
Methods: During the period between June 2023 and April 2024, we evaluated patients undergoing CTO PCI at eight participating centers for scheduled clinically necessary CTO PCI with a planned primary antegrade approach using an upfront agreed ReCross strategy.
Results: A total of 118 patients who underwent CTO PCI were included in the study. The mean JCTO score was 2.16 ± 0.95. The majority of cases (94%) were successfully resolved using an upfront ReCross strategy with a technical success of 96%, demonstrating a high level of effectiveness. The average procedure time (90 min) observed in our study was notably lower in comparison to other similar studies. There were no procedure-related mortalities until hospital discharge, although one distal wire perforation complication was reported.
Conclusion: Our initial experience with the ReCross microcatheter suggests in select cases with the application of a dedicated algorithm, the antegrade approach can be highly successful.
期刊介绍：
Catheterization and Cardiovascular Interventions is an international journal covering the broad field of cardiovascular diseases. Subject material includes basic and clinical information that is derived from or related to invasive and interventional coronary or peripheral vascular techniques. The journal focuses on material that will be of immediate practical value to physicians providing patient care in the clinical laboratory setting. To accomplish this, the journal publishes Preliminary Reports and Work In Progress articles that complement the traditional Original Studies, Case Reports, and Comprehensive Reviews. Perspective and insight concerning controversial subjects and evolving technologies are provided regularly through Editorial Commentaries furnished by members of the Editorial Board and other experts. Articles are subject to double-blind peer review and complete editorial evaluation prior to any decision regarding acceptability.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
